Automated production of gene-modified chimeric antigen receptor T cells using the Cocoon Platform
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy
Reference36 articles.
1. Treatment of patients with metastatic cancer using major histocompatibility complex Class II-restricted T-cell receptor targeting the cancer germline antigen MAGE-A3;Lu;J. Clin. Oncol.,2017
2. First-in-human multicenter study of bb2121 anti-BCMA CAR T-cell therapy for relapsed/refractory multiple myeloma: updated results;Berdeja;J. Clin. Oncol.,2017
3. Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells;Kebriaei;J. Clin Invest.,2016
4. National Cancer Institute. CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers 2022 https://www.cancer.gov/about-cancer/treatment/research/car-t-cells (accessed May 4, 2023).
5. Global manufacturing of CAR T cell therapy;Levine;Mol. Ther. Methods Clin. Dev.,2017
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. CAR-T cell manufacturing: Major process parameters and next-generation strategies;Journal of Experimental Medicine;2024-01-16
2. Development of a robotic cluster for automated and scalable cell therapy manufacturing;2023-12-23
3. Broadening the horizon: potential applications of CAR-T cells beyond current indications;Frontiers in Immunology;2023-11-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3